Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Feb;79(3-4):416–422. doi: 10.1038/sj.bjc.6690065

Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions

M Sakaguchi 1, A K Virmani 1,2, R Ashfaq 2, T E Rogers 2,3, A Rathi 1, Y Liu 1, D Kodagoda 1, H T Cunningham 1, A F Gazdar 1,2
PMCID: PMC2362411  PMID: 10027307

Abstract

We developed a sensitive and specific method for the detection of epithelial cancer cells in effusions with a two-stage molecular-based assay which combined enrichment for cancer cells by immunomagnetic bead selection and reverse transcriptase polymerase chain reaction (RT-PCR) detection of epithelial glycoprotein 2 (EGP-2) RNA. Preliminary experiments indicated that immunobead selection was essential to avoid occasional false-positive RT-PCR results, and this method detected ten breast cancer cells electively added to 107 cytologically negative effusion cells. We studied 110 cases of pleural (n = 68) and peritoneal (n = 42) effusions (30 from patients with known carcinoma and 80 from those without known carcinoma), and the results were compared with cytological findings. Of 18 effusions that were cytologically positive or suspicious for malignant cells, 17 (94%) were positive for EGP-2 RNA (the one negative sample was from a patient who recently received combination chemotherapy). Of 92 cytologically negative samples, 11 (12%) were positive for EGP-2, including six patients with a history of previous or current carcinoma. Our method appears to be highly specific and increases the sensitivity of detection of malignant cells; it may be a useful adjunct to routine cytopathological examination. © 1999 Cancer Research Campaign

Keywords: epithelial glycoprotein 2, cytokeratin 19, reverse transcriptase polymerase chain reaction, effusion

Full Text

The Full Text of this article is available as a PDF (234.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burchill S. A., Bradbury M. F., Pittman K., Southgate J., Smith B., Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995 Feb;71(2):278–281. doi: 10.1038/bjc.1995.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Datta Y. H., Adams P. T., Drobyski W. R., Ethier S. P., Terry V. H., Roth M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar;12(3):475–482. doi: 10.1200/JCO.1994.12.3.475. [DOI] [PubMed] [Google Scholar]
  3. De Angelis M., Buley I. D., Heryet A., Gray W. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4. Cytopathology. 1992;3(2):111–117. doi: 10.1111/j.1365-2303.1992.tb00033.x. [DOI] [PubMed] [Google Scholar]
  4. Eaton M. C., Hardingham J. E., Kotasek D., Dobrovic A. Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. Biotechniques. 1997 Jan;22(1):100–105. doi: 10.2144/97221st01. [DOI] [PubMed] [Google Scholar]
  5. Fields K. K., Elfenbein G. J., Trudeau W. L., Perkins J. B., Janssen W. E., Moscinski L. C. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol. 1996 Jun;14(6):1868–1876. doi: 10.1200/JCO.1996.14.6.1868. [DOI] [PubMed] [Google Scholar]
  6. Gazdar A. F., Oie H. K. Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986 Nov;46(11):6011–6012. [PubMed] [Google Scholar]
  7. Hardingham J. E., Kotasek D., Farmer B., Butler R. N., Mi J. X., Sage R. E., Dobrovic A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 1993 Aug 1;53(15):3455–3458. [PubMed] [Google Scholar]
  8. Hardingham J. E., Kotasek D., Sage R. E., Eaton M. C., Pascoe V. H., Dobrovic A. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med. 1995 Nov;1(7):789–794. [PMC free article] [PubMed] [Google Scholar]
  9. Illingworth A. L., Young J. A., Johnson G. D. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4. Cytopathology. 1994 Oct;5(5):270–281. doi: 10.1111/j.1365-2303.1994.tb00431.x. [DOI] [PubMed] [Google Scholar]
  10. Katz A. E., Olsson C. A., Raffo A. J., Cama C., Perlman H., Seaman E., O'Toole K. M., McMahon D., Benson M. C., Buttyan R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology. 1994 Jun;43(6):765–775. doi: 10.1016/0090-4295(94)90132-5. [DOI] [PubMed] [Google Scholar]
  11. Krismann M., Todt B., Schröder J., Gareis D., Müller K. M., Seeber S., Schütte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol. 1995 Nov;13(11):2769–2775. doi: 10.1200/JCO.1995.13.11.2769. [DOI] [PubMed] [Google Scholar]
  12. Latza U., Niedobitek G., Schwarting R., Nekarda H., Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol. 1990 Mar;43(3):213–219. doi: 10.1136/jcp.43.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Maguire B., Whitaker D., Carrello S., Spagnolo D. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens. Diagn Cytopathol. 1994;10(2):130–134. doi: 10.1002/dc.2840100207. [DOI] [PubMed] [Google Scholar]
  14. Noguchi S., Aihara T., Motomura K., Inaji H., Imaoka S., Koyama H. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer. 1996 Sep 15;78(6):1235–1240. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1235::AID-CNCR10>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  15. Noguchi S., Hiratsuka M., Furukawa H., Aihara T., Kasugai T., Tamura S., Imaoka S., Koyama H., Iwanaga T. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1996 Jun;87(6):650–654. doi: 10.1111/j.1349-7006.1996.tb00272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nomoto S., Nakao A., Kasai Y., Harada A., Nonami T., Takagi H. Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res. 1996 Aug;87(8):793–797. doi: 10.1111/j.1349-7006.1996.tb02102.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pelkey T. J., Frierson H. F., Jr, Bruns D. E. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem. 1996 Sep;42(9):1369–1381. [PubMed] [Google Scholar]
  18. Schoenfeld A., Luqmani Y., Smith D., O'Reilly S., Shousha S., Sinnett H. D., Coombes R. C. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994 Jun 1;54(11):2986–2990. [PubMed] [Google Scholar]
  19. Sheibani K., Shin S. S., Kezirian J., Weiss L. M. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol. 1991 Aug;15(8):779–784. doi: 10.1097/00000478-199108000-00008. [DOI] [PubMed] [Google Scholar]
  20. Simon B., Podolsky D. K., Moldenhauer G., Isselbacher K. J., Gattoni-Celli S., Brand S. J. Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2755–2759. doi: 10.1073/pnas.87.7.2755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tickman R. J., Cohen C., Varma V. A., Fekete P. S., DeRose P. B. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry. Acta Cytol. 1990 Jul-Aug;34(4):491–496. [PubMed] [Google Scholar]
  22. Traweek S. T., Liu J., Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol. 1993 Apr;142(4):1111–1118. [PMC free article] [PubMed] [Google Scholar]
  23. Wu Y. J., Parker L. M., Binder N. E., Beckett M. A., Sinard J. H., Griffiths C. T., Rheinwald J. G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell. 1982 Dec;31(3 Pt 2):693–703. doi: 10.1016/0092-8674(82)90324-5. [DOI] [PubMed] [Google Scholar]
  24. Zippelius A., Kufer P., Honold G., Köllermann M. W., Oberneder R., Schlimok G., Riethmüller G., Pantel K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol. 1997 Jul;15(7):2701–2708. doi: 10.1200/JCO.1997.15.7.2701. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES